Sign in or create an account to add this stock to your watchlist.
About Ista Pharmaceuticals (NASDAQ:ISTA)
ISTA Pharmaceuticals, Inc. (ISTA) is a commercial-stage, multi-specialty pharmaceutical company. The Company is engaged in developing, marketing and selling its own products in the United States and Puerto Rico. ISTA is a prescription eye care business in the United States and has an allergy drug franchise. ISTA manufactures its finished good products through third-party contracts. ISTA in-licenses or acquires new products and technologies to add to its internal development. Its products and product candidates seek to treat allergy and diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye and ocular and nasal allergies. It has four products available for sale in the United States and Puerto Rico: BROMDAY (bromfenac ophthalmic solution) 0.09%, BEPREVE (bepotastine besilate ophthalmic solution) 1.5%, ISTALOL (timolol maleate ophthalmic solution) 0.5% and VITRASE (hyaluronidase injection).
Industry, Sector and Symbol
Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNASDAQ:ISTA
CUSIPN/A
Phone+1-949-7886000
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Ista Pharmaceuticals (NASDAQ:ISTA) Frequently Asked Questions
What is Ista Pharmaceuticals' stock symbol?
Ista Pharmaceuticals trades on the NASDAQ under the ticker symbol "ISTA."
Has Ista Pharmaceuticals been receiving favorable news coverage?
News headlines about ISTA stock have been trending somewhat positive on Thursday, according to Accern Sentiment. The research firm scores the sentiment of news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Ista Pharmaceuticals earned a news sentiment score of 0.17 on Accern's scale. They also gave news stories about the specialty pharmaceutical company an impact score of 46.43 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Ista Pharmaceuticals?
Shares of ISTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Ista Pharmaceuticals?
Ista Pharmaceuticals' mailing address is #D1, 10574 Acacia Street, RANCHO CUCAMONGA, CA 91730, United States. The specialty pharmaceutical company can be reached via phone at +1-949-7886000.
MarketBeat Community Rating for Ista Pharmaceuticals (ISTA)
MarketBeat's community ratings are surveys of what our community members think about Ista Pharmaceuticals and other stocks. Vote "Outperform" if you believe ISTA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISTA will underperform the S&P 500 over the long term. You may vote once every thirty days.
Ista Pharmaceuticals (NASDAQ:ISTA) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
(Data available from 5/24/2016 forward)
Ista Pharmaceuticals (NASDAQ:ISTA) Earnings History and Estimates Chart
Ista Pharmaceuticals (NASDAQ ISTA) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 5/3/2012 | | ($0.11) | ($0.43) | | | View | N/A |  |
| 2/23/2012 | | $0.21 | $0.25 | | | View | N/A | |
| 11/1/2011 | | $0.09 | $0.09 | | | View | N/A | |
| 7/28/2011 | | $0.04 | ($0.11) | | | View | N/A | |
| 5/5/2011 | | ($0.15) | ($0.17) | | | View | N/A | |
| 2/23/2011 | | $0.09 | $0.14 | | | View | N/A | |
| 11/2/2010 | Q3 2010 | $0.04 | $0.08 | | | View | N/A | |
| 4/30/2010 | Q1 2010 | ($0.12) | ($0.20) | | | View | N/A | |
| 2/23/2010 | Q4 2009 | | $0.03 | | | View | N/A | |
| 8/5/2009 | Q2 2009 | ($0.09) | ($0.08) | | | View | N/A | |
| 5/7/2009 | Q1 2009 | ($0.19) | ($0.19) | | | View | N/A | |
| 2/19/2009 | Q4 2008 | ($0.09) | ($0.06) | | | View | N/A | |
| 10/30/2008 | Q3 2008 | ($0.23) | ($0.22) | | | View | N/A | |
| 8/7/2008 | Q2 2008 | ($0.29) | ($0.26) | | | View | N/A | |
| 4/30/2008 | Q1 2008 | ($0.38) | ($0.39) | | | View | N/A | |
| 3/6/2008 | Q4 2007 | ($0.28) | ($0.30) | | | View | N/A | |
(Earnings results data provided by Zacks Investment Research)
Ista Pharmaceuticals (NASDAQ:ISTA) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
Ista Pharmaceuticals (NASDAQ ISTA) Insider Trading and Institutional Ownership History
Ista Pharmaceuticals (NASDAQ ISTA) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
(Data available from 1/1/2013 forward)
Ista Pharmaceuticals (NASDAQ ISTA) News Headlines
| Source: |
|
Ista Pharmaceuticals (NASDAQ:ISTA) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Ista Pharmaceuticals (NASDAQ:ISTA) Income Statement, Balance Sheet and Cash Flow Statement
Ista Pharmaceuticals (NASDAQ ISTA) Stock Chart for Thursday, May, 24, 2018
Loading chart…
